Response to correspondence 'Reasons against routine determination of plasma trough levels in PWH treated with intramuscular long acting cabotegravir and rilpivirine as of today'
Clin Infect Dis. 2024 Mar 14:ciae142.
doi: 10.1093/cid/ciae142.
Online ahead of print.